These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 33123969)

  • 41. How 4 Companies Became One: Co-development Under an Outsourced Model With Focus on Phase 3 Analysis and Reporting Deliverables.
    Huyck S; Golm G; Ghani S; Mancuso J; Irvin T
    Ther Innov Regul Sci; 2019 May; 53(3):301-306. PubMed ID: 29911403
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Determinants of information technology outsourcing among health maintenance organizations.
    Wholey DR; Padman R; Hamer R; Schwartz S
    Health Care Manag Sci; 2001 Sep; 4(3):229-39. PubMed ID: 11519848
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The quiet revolution: outsourcing in pharma.
    Crossley R
    Drug Discov Today; 2004 Aug; 9(16):694. PubMed ID: 15341780
    [No Abstract]   [Full Text] [Related]  

  • 44. Epidemiology in the pharmaceutical industry.
    Roht LH; Shinaberry L; Maybury L; Liao I; Riley E; Andrews EB; Siegfried JD
    Pharmacoepidemiol Drug Saf; 2000 Mar; 9(2):139-48. PubMed ID: 19025814
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of the COVID-19 Pandemic on Pharmacovigilance Strategy, Systems, and Processes of Large, Medium, and Small Companies: An Industry Survey.
    Beninger P; Caubel P; Sharma L; Pajovich G; Boyd P
    Clin Ther; 2022 Sep; 44(9):1225-1236. PubMed ID: 35940940
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The critical phase inspection process: a benchmarking study in search of industries' best practices.
    Herman DR; Dangler TL; Houser DA; Lewis TG; Masten JL; Taylor IE
    Qual Assur; 1993; 2(1-2):186-90. PubMed ID: 8156211
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Equipment and analytical companies meeting continuous challenges. May 20-21, 2014 Continuous Manufacturing Symposium.
    Page T; Dubina H; Fillipi G; Guidat R; Patnaik S; Poechlauer P; Shering P; Guinn M; Mcdonnell P; Johnston C
    J Pharm Sci; 2015 Mar; 104(3):821-31. PubMed ID: 25448273
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Collaboration versus outsourcing: the need to think outside the box.
    Robertson GM; Mayr LM
    Future Med Chem; 2011 Dec; 3(16):1995-2020. PubMed ID: 22098350
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Small molecule compound logistics outsourcing--going beyond the "thought experiment".
    Ramsay DL; Kwasnoski JD; Caldwell GW
    Curr Top Med Chem; 2012; 12(11):1298-308. PubMed ID: 22571792
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Outsourcing information technology. An executive's guide to creating and managing IT contracts.
    Hoppszallern S
    Hosp Health Netw; 2003 Jan; 77(1):45-50, 1. PubMed ID: 12569744
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Early achievements of the Danish pharmaceutical industry--8. Lundbeck].
    Grevsen JV; Kirkegaard H; Kruse E; Kruse PR
    Theriaca; 2016; (43):9-61. PubMed ID: 27491172
    [TBL] [Abstract][Full Text] [Related]  

  • 52. To outsource or not to outsource: Examining the effects of outsourcing IT functions on financial performance in hospitals.
    Menachemi N; Burkhardt J; Shewchuk R; Burke D; Brooks RG
    Health Care Manage Rev; 2007; 32(1):46-54. PubMed ID: 17245202
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bioanalytical outsourcing strategy at Janssen Research and Development.
    Verhaeghe T
    Bioanalysis; 2014 May; 6(10):1321-7. PubMed ID: 24958116
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Conference report: a hitchhiker's guide to outsourcing ADME studies: the inside of outsourcing.
    Pritchard JF; Anderson SR; Breuckner C; Premkumar ND; Polli JW
    Bioanalysis; 2013 Feb; 5(4):403-5. PubMed ID: 23414372
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Outsourcing your medical practice call center: how to choose a vendor to ensure regulatory compliance.
    Johnson B
    J Med Pract Manage; 2014; 30(2):124-7. PubMed ID: 25807604
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Aspects of research and development contract terms in the bio/pharmaceutical sector.
    Banerjee T
    Adv Health Econ Health Serv Res; 2012; 23():1-33. PubMed ID: 23156659
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical trials in India.
    Maiti R; M R
    Pharmacol Res; 2007 Jul; 56(1):1-10. PubMed ID: 17391981
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In search of a benchmark: a proposed standard efficiency rating for air medical billing services.
    Stults KR
    Air Med J; 2007; 26(2):90-5. PubMed ID: 17346645
    [No Abstract]   [Full Text] [Related]  

  • 59. Strategy and additive technologies as the catalyst for outsourcing, process innovation and operational effectiveness.
    Tegethoff T; Santa R; Cayón E; Scavarda A
    PLoS One; 2023; 18(2):e0282366. PubMed ID: 36848342
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An evaluation of health information technology outsourcing success.
    Malovec SN; Borycki EM; Kushniruk AW
    Stud Health Technol Inform; 2015; 208():253-7. PubMed ID: 25676983
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.